← FDA Drug Approvals (Drugs@FDA)

REVATIO

NDA · New Drug Application · Sponsor: VIATRIS · Approved 2009-11-18

Drug application

FDA Application #

NDA022473

Application type

New Drug Application

Brand name

REVATIO

Generic name

SILDENAFIL CITRATE

Active ingredients

SILDENAFIL CITRATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

VIATRIS

Manufacturer

Viatris Specialty LLC

First approval

2009-11-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown